-
Loading metrics
Open Access
Peer-reviewed
Research Article
Characterization and Plasma Measurement of the WE-14 Peptide in Patients with Pheochromocytoma
-
Johann Guillemot,
Affiliations Institut National de la Santé et de la Recherche Médicale (INSERM), U982, Mont-Saint-Aignan, France, Normandy University, Normandy, France, Rouen University, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine (IRIB), Mont-Saint-Aignan, France, Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, Montreal, Quebec, Canada
⨯ -
Marlène Guérin,
Affiliations Institut National de la Santé et de la Recherche Médicale (INSERM), U982, Mont-Saint-Aignan, France, Normandy University, Normandy, France, Rouen University, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine (IRIB), Mont-Saint-Aignan, France
⨯ -
Erwan Thouënnon,
Affiliations Institut National de la Santé et de la Recherche Médicale (INSERM), U982, Mont-Saint-Aignan, France, Normandy University, Normandy, France, Rouen University, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine (IRIB), Mont-Saint-Aignan, France
⨯ -
Maité Montéro-Hadjadje,
Affiliations Institut National de la Santé et de la Recherche Médicale (INSERM), U982, Mont-Saint-Aignan, France, Normandy University, Normandy, France, Rouen University, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine (IRIB), Mont-Saint-Aignan, France
⨯ -
Jérôme Leprince,
Affiliations Institut National de la Santé et de la Recherche Médicale (INSERM), U982, Mont-Saint-Aignan, France, Normandy University, Normandy, France, Rouen University, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine (IRIB), Mont-Saint-Aignan, France
⨯ -
Hervé Lefebvre,
Affiliations Institut National de la Santé et de la Recherche Médicale (INSERM), U982, Mont-Saint-Aignan, France, Normandy University, Normandy, France, Rouen University, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine (IRIB), Mont-Saint-Aignan, France, Department of Endocrinology, Diabetes and Metabolic Diseases, Rouen University Hospital, Bois-Guillaume, France
⨯ -
Marc Klein,
Affiliation Department of Endocrinology, Hôpital de Brabois, University of Nancy, Nancy, France
⨯ -
Mihaela Muresan,
Affiliation Unit of Endocrinology, Hôpital Notre-Dame de Bon Secours, Metz, France
⨯ -
Youssef Anouar,
Affiliations Institut National de la Santé et de la Recherche Médicale (INSERM), U982, Mont-Saint-Aignan, France, Normandy University, Normandy, France, Rouen University, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine (IRIB), Mont-Saint-Aignan, France
⨯ -
Laurent Yon
* E-mail: laurent.yon@univ-rouen.fr
Affiliations Institut National de la Santé et de la Recherche Médicale (INSERM), U982, Mont-Saint-Aignan, France, Normandy University, Normandy, France, Rouen University, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine (IRIB), Mont-Saint-Aignan, France
⨯
Characterization and Plasma Measurement of the WE-14 Peptide in Patients with Pheochromocytoma
- Johann Guillemot,
- Marlène Guérin,
- Erwan Thouënnon,
- Maité Montéro-Hadjadje,
- Jérôme Leprince,
- Hervé Lefebvre,
- Marc Klein,
- Mihaela Muresan,
- Youssef Anouar,
- Laurent Yon
- Published: February 11, 2014
- https://doi.org/10.1371/journal.pone.0088698